Danaher Corporation Reports Second Quarter 2025 Earnings
Danaher Corporation (NYSE: DHR) has announced its second quarter financial results for 2025, showcasing a strong performance in various segments. The quarter concluded with net earnings of $555 million, translating into diluted earnings per share of $0.77. When adjusted to exclude certain items, the non-GAAP diluted earnings per share reached $1.80, indicating strong operational profitability.
Key Financial Highlights
Revenue for the quarter amounted to $5.9 billion, reflecting an increase of 3.5% year-over-year. Core revenues, adjusted for acquisitions and currency effects, grew by 1.5%. The company illustrated robust operating cash flow of $1.3 billion and non-GAAP free cash flow of $1.1 billion during the quarter, demonstrating effective cash management amid changing market conditions.
Leadership Insights
Rainer M. Blair, President and CEO of Danaher, expressed pride in the team's execution and commitment to growth, stating that "Our use of the Danaher Business System has fostered another strong quarter for our bioprocessing business. Despite uncertainties in the broader macroeconomic landscape, we are confident in our ability to create long-term value for shareholders, driven by our unique portfolio and robust financial health."
Outlook for 2025
Looking ahead, Danaher anticipates that core sales growth for the third quarter will be in the low-single digits compared to the previous year. The company maintains its full-year guidance for non-GAAP core revenue growth at approximately 3%. Additionally, Danaher has raised its adjusted diluted net earnings per share guidance to a range of $7.70 to $7.80 for the full year.
Conference Call Information
The company will host an investor conference call to discuss its second quarter results and updated financial guidance for the third quarter. The call is expected to begin at 8:00 a.m. ET and will be available for replay shortly after its conclusion.
About Danaher
Danaher is a prominent entity in the global life sciences and diagnostics sector. The organization is dedicated to accelerating advancements in science and technology that enhance human health. With about 63,000 employees worldwide, Danaher collaborates closely with clients to tackle significant health challenges and contribute to improving quality of life.
Frequently Asked Questions
What were Danaher's net earnings for the second quarter of 2025?
Danaher reported net earnings of $555 million for the second quarter of 2025.
What is the adjusted diluted earnings per share for Danaher in 2025?
For the second quarter of 2025, Danaher's adjusted diluted earnings per share stood at $1.80.
How much did Danaher earn in revenue for the second quarter of 2025?
Danaher generated $5.9 billion in revenue during the second quarter of 2025, marking a 3.5% year-over-year increase.
What is the forecast for Danaher's core sales growth in 2025?
Danaher anticipates low-single digit core sales growth for the third quarter and approximately 3% growth for the entire year.
How does Danaher define free cash flow?
Free cash flow is defined as the net cash provided by operating activities, less payments for additions to property and equipment, plus proceeds from sales of assets.
